Mookerjee
Avijit Mookerjee, Allentown, PA US
Patent application number | Description | Published |
---|---|---|
20120325821 | CRYOGENIC STORAGE TANK - An apparatus and method for constructing a cryogenic storage tank ( | 12-27-2012 |
Bijoyesh Mookerjee, Collegeville, PA US
Patent application number | Description | Published |
---|---|---|
20160106809 | METHODS OF TREATING CANCER - Methods of treating cancers comprising administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule are provided. Methods of treating cancers comprising administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule and at least one anti-angiogenic agent are provided. | 04-21-2016 |
Neelhoffer Mookerjee, Winnipeg CA
Patent application number | Description | Published |
---|---|---|
20150050291 | DETECTION AND MODULATION OF RHEUMATOID ARTHRITIS - A method for detecting and/or monitoring a chronic inflammation condition associated with rheumatoid arthritis. The method comprises the steps of: (i) collecting a sample; (ii) detecting in the sample, one or more of a HMGN1 protein, a LCP-1 protein, a prtn3 protein, a sec22b protein, and a PYGL glycogen phosphorylase protein thereby producing a result; and (iii) correlating the result with a control. A test kit for diagnosing or monitoring a chronic inflammatory condition associated with rheumatoid arthritis. The test kit comprises an antibody for complexing with one of a HMGN1 protein, a LCP-1 protein, a prtn3 protein, a sec22b protein, and a PYGL glycogen phosphorylase protein. A composition for treatment of a chronic inflammation condition associated with rheumatoid arthritis, comprising a therapeutically effective amount of an exogenous agonist for decreasing cellular production of one or more of a HMGN1 protein, a LCP-1 protein, a prtn3 protein, a sec22b protein, and a PYGL glycogen phosphorylase protein. | 02-19-2015 |
Pradip Mookerjee, Flemington, NJ US
Patent application number | Description | Published |
---|---|---|
20090312279 | Antimicrobial compositions - An antimicrobial composition, including a synergistic combination of three or more agents as an active ingredient. Each of the three or more potentiating agents can be selected from the following types of compounds: sequestering agents, carbohydrates and carbohydrate derivatives, terpenes/terpenoids, amines and amine derivatives, plant-derived oils, sulfonates, phenols, fatty acids, dibenzofuran derivatives, organo isothiocyanates, quaternary ammonium compounds, peroxides and peroxide donors, and macrolide polyenes. At least two of the three or more potentiating agents are not of the same type of compound. The antimicrobial composition can have strong antimicrobial efficacy in control of microorganisms having resistance to currently used antimicrobials. | 12-17-2009 |
20120121723 | Antimicrobial Compositions - An antimicrobial composition, including a synergistic combination of three or more agents as an active ingredient. Each of the three or more potentiating agents can be selected from the following types of compounds: sequestering agents, carbohydrates and carbohydrate derivatives, terpenes/terpenoids, amines and amine derivatives, plant-derived oils, sulfonates, phenols, fatty acids, dibenzofuran derivatives, organo isothiocyanates, quaternary ammonium compounds, peroxides and peroxide donors, and macrolide polyenes. At least two of the three or more potentiating agents are not of the same type of compound. The antimicrobial composition can have strong antimicrobial efficacy in control of microorganisms having resistance to currently used antimicrobials. | 05-17-2012 |
Purusottam Mookerjee, Bridgewater, NJ US
Patent application number | Description | Published |
---|---|---|
20110025551 | Burnout time estimation and early thrust termination determination for a boosting target - A system senses the presence of a boosting missile or target and processes the information by comparison of the data with a plurality of predetermined templates of nominal missile characteristics, in order to determine the state of the missile. The processing includes estimation of burnout time and of early thrust termination. Both are determined by generating current stage state estimates including position, velocity, time index error into the thrust template, and motor scale factor error. The change in motor scale factor is compared with a threshold to determine if early thrust termination has occurred. The estimated burnout time of the current stage is calculated from the burnout times of the current and the previous stage processed with the estimated motor scale factor and with state estimates from a filter. | 02-03-2011 |
Radha Mookerjee, Mckinney, TX US
Patent application number | Description | Published |
---|---|---|
20130124344 | METHOD AND SYSTEM FOR DETERMINING USER LIKELIHOOD TO SELECT AN ADVERTISEMENT PRIOR TO DISPLAY - A computer implemented system and method of determining whether to display an advertisement to a user can include determining, using at least one processor, a likelihood that a user accessing a web page would select an advertisement if displayed to the user in the web page at a future moment during that trip by the user to the web page. An analysis module can determine whether or not the determined likelihood satisfies criteria imposed by a click-through-rate associated with the web page. If the determined likelihood value satisfies the click-through-rate, then an advertisement can be output to the user through at least one output device. Otherwise, the system can refrain from causing an advertisement to be output to the user for inclusion in the web page during that particular visit by the user to the web page. | 05-16-2013 |
Rajeshwar P. Mookerjee, London GB
Patent application number | Description | Published |
---|---|---|
20090280519 | BIOMARKERS FOR ASSESSING LIVER FUNCTION - A method for assessing liver function in an individual, which method comprises determining the level of methylarginine(s) (such as ADMA and/or SDMA) and the ratio of ischemia modified albumin (IMA):albumin ratio (IMAR) in the individual, thereby to assess liver function in the individual. | 11-12-2009 |
20100297018 | Prognosis and therapy of liver failure - A method for assessing prognosis in an individual suffering from liver failure, which method comprises detecting endotoxin in the individual, for example by determining the neutrophil function in the individual. The method can be used to determine whether there is an increased risk of infection in the individual, an increased risk of organ failure in the individual, an increased risk of mortality in the individual and/or an increased risk that the individual will not respond positively to treatment with an immunosuppressive agent, a steroid or an antibiotic. | 11-25-2010 |
20120237503 | Screening Method and Therapy with Agonists of DDAH I - The present invention derives from the finding that decreased levels of DDAH I are associated with increased portal pressure and that by increasing DDAH I levels in vivo, portal pressure may be reduced. Accordingly, the invention provides methods for reducing portal blood pressure comprising administering to a subject in need thereof an agonist of DDAH I. | 09-20-2012 |
20130237557 | TREATMENT - The present invention derives from the finding that increased levels of alpha 2a adrenergic receptors (ADRA2a) are associated with chronic liver disease and that by decreasing ADRA2a levels in vivo, a number of symptoms and consequences of chronic liver disease may be reduced. Accordingly, the invention provides ADRA2a antagonists for use in a method of treating an individual suffering from liver disease. | 09-12-2013 |
Vijay Mookerjee, Mckinney, TX US
Patent application number | Description | Published |
---|---|---|
20130124344 | METHOD AND SYSTEM FOR DETERMINING USER LIKELIHOOD TO SELECT AN ADVERTISEMENT PRIOR TO DISPLAY - A computer implemented system and method of determining whether to display an advertisement to a user can include determining, using at least one processor, a likelihood that a user accessing a web page would select an advertisement if displayed to the user in the web page at a future moment during that trip by the user to the web page. An analysis module can determine whether or not the determined likelihood satisfies criteria imposed by a click-through-rate associated with the web page. If the determined likelihood value satisfies the click-through-rate, then an advertisement can be output to the user through at least one output device. Otherwise, the system can refrain from causing an advertisement to be output to the user for inclusion in the web page during that particular visit by the user to the web page. | 05-16-2013 |